The team’s study results, published today in the journal Immunity, outline their discovery of a specific type of regulatory T cell that can home back into the thymus and repair the organ when it ...
“Our discovery—the regulatory T cell recirculation back to the thymus—promotes repair through a process that hasn’t been described before and represents a novel pathway to regeneration ...
A third phase 3 trial is running in patients with lung and thymus neuroendocrine tumors, according to the release, as well as a phase 1 pediatric trial in SSTR-positive tumors. ITM is not putting ...
A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback